WallStreetZenWallStreetZen

NASDAQ: ALPN
Alpine Immune Sciences Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ALPN past revenue growth

How has ALPN's revenue growth performed historically?
Company
95.84%
Industry
154.55%
Market
17.87%
ALPN's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ALPN's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ALPN's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ALPN earnings and revenue history

Current Revenue
$58.9M
Current Earnings
-$32.2M
Current Profit Margin
-54.7%

ALPN Return on Equity

Current Company
-15.5%
Current Industry
-63.5%
Current Market
188%
ALPN's Return on Equity (-15.5%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ALPN announces earnings.

ALPN Return on Assets

Current Company
-11.3%
Current Industry
2.9%
ALPN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ALPN Return on Capital Employed

Current Company
-9.47%
Current Industry
19.5%
ALPN has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ALPN vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ALPN$58.88M-$31.41M-$32.18M+142.30%N/A
NUVL$0.00-$126.22M-$126.22MN/AN/A
IMVT$0.00-$242.72M-$243.45MN/AN/A
INSM$305.21M-$645.53M-$749.57M+98.78%N/A
BBIO$9.30M-$551.39M-$643.20M-30.80%N/A
View Top Biotech Stocks

ALPN earnings dates

Next earnings date
May 9, 2024

Alpine Immune Sciences Earnings & Revenue FAQ

What were ALPN's earnings last quarter?

On Invalid Date, Alpine Immune Sciences (NASDAQ: ALPN) reported Q4 2023 earnings per share (EPS) of $0.15, up 130% year over year. Total Alpine Immune Sciences earnings for the quarter were $5.96 million. In the same quarter last year, Alpine Immune Sciences's earnings per share (EPS) was -$0.50.

If you're new to stock investing, here's how to buy Alpine Immune Sciences stock.

What was ALPN's earnings growth in the past year?

As of Q2 2024, Alpine Immune Sciences's earnings has grown year over year. Alpine Immune Sciences's earnings in the past year totalled -$32.18 million.

What is ALPN's earnings date?

Alpine Immune Sciences's earnings date is Invalid Date. Add ALPN to your watchlist to be reminded of ALPN's next earnings announcement.

What was ALPN's revenue last quarter?

On Invalid Date, Alpine Immune Sciences (NASDAQ: ALPN) reported Q4 2023 revenue of $30.85 million up 1,011.42% year over year. In the same quarter last year, Alpine Immune Sciences's revenue was $2.78 million.

What was ALPN's revenue growth in the past year?

As of Q2 2024, Alpine Immune Sciences's revenue has grown 95.84% year over year. This is 58.72 percentage points lower than the US Biotechnology industry revenue growth rate of 154.55%. Alpine Immune Sciences's revenue in the past year totalled $58.88 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.